Leinco Technologies, Inc. develops, manufactures, and commercializes the highest purity antibodies (monoclonal, recombinant, and polyclonal), biologically active proteins, and assays to support reproducible science across diverse applications, including neuroscience, pre-clinical studies, spatial biology, and flow cytometry. Operating in an animal-free facility and adhering to ISO 9001:2015 and ISO 13485:2016 quality standards, Leinco also offers CDMO services such as antibody scale-up and purification, optimized conjugation to reporter molecules, and assay development and manufacturing.